DDI Team

The Drug Development Institute is led by a team of highly experienced research and drug development scientists with:

  • Diversified industrial experience along the drug development value chain
  • Proven track records of delivering novel compounds and technologies for clinical development
  • Experience in managing projects using data-driven, milestone-based project management
Erandi De Silva

Erandi De Silva, PhD – Molecular Biologist


Email: erandi.desilva@osumc.edu | Phone: 614-685-8869

Dr. De Silva earned her PhD in molecular biology at Princeton and completed her postdoctoral research at Genentech. Erandi brings biology and project-management experience to the DDI.

Chad Bennett

Chad Bennett, PhD – Medicinal & Process Chemist


Email: chad.bennett@osumc.edu | Phone: 614-685-9230

Dr. Bennett has over 10 years of experience in the pharmaceutical industry at Merck and Schering-Plough, working in both the discovery and early-development phases.

Larry Scharff

Larry Schaaf, PhD – Clinical Pharmacologist


Email: larry.schaaf@osumc.edu | Phone: 614-293-6851

Dr. Schaaf has more than 25 years of experience performing clinical pharmacology assessments in the pharmaceutical industry and academia. Larry has held positions within Upjohn, Pharmacia and Pfizer, and he directed the OSUCCC – James Phase I Unit for 11 years.

Cindi Evans

Cindy Evans – Administrative Assistant


Email: ddi@osumc.edu | Phone: 614-685-6957

For more information, contact the DDI team members individually or at ddi@osumc.edu.

Contact the DDI

Email: ddi@osumc.edu
Phone: 614-685-6957